Acceleration Initiative

Acceleration Initiative – An Outcome Driven Approach

Our Acceleration Initiative projects are highly innovative, address a significant challenge in pediatric cancer drug development, and have a strong probability of clinical application — ready to reach patients within three to five years. To learn more about applying for one of our grants, click here.

ACCELERATION INITIATIVE – ACTIVE PROJECTS

Gregory Friedman, MD
University of Alabama at Birmingham
Focus: Pediatric High-Grade Glioma
Project title: Overcoming the Adverse Microenvironment of Pediatric High-Grade Gliomas

David Langenau, PhD
Massachusetts General Hospital
Focus: Rhabdomyosarcoma
Project Title:Targeting p53 in childhood rhabdomyosarcoma

Dr. Andrei Thomas-Tikhonenko – The Children’s Hospital of Philadelphia

Andrei Thomas-Tikhonenko, PhD
Children’s Hospital of Philadelphia
Focus: High-risk Pediatric Cancers – Neuroblastoma and Diffuse Midline Glioma
Project title: Targeting splicing-derived neo-epitopes in high-risk pediatric cancers

Frequently Asked Questions

How can I be notified of new RFAs?

When does the application window open to submit Letters of Intent (LOIs)?

Who can I contact with questions?

ACCELERATION INITIATIVE - COMPLETED PROJECTS

Mary Beckerle, PhD
Ewing Sarcoma

William Weiss, MD, PhD
Medulloblastoma

Richard Gilbertson, MD, PhD
Brain Cancer

Andrew Kung, MD, PhD
Pediatric Sarcoma

Maria-Grazia Roncarolo, MD
Acute Myeloid Leukemia (AML)

TIMELINE	DATES
Request for Applications Opens	Early June
Letter of Intent Deadline	Mid-July
LOI Notification/Full Applications Invited	Early September
Full Applications Due	Mid-October
Earliest Award Notification*	Early January

Acceleration Initiative

ACCELERATION INITIATIVE – ACTIVE PROJECTS

Frequently Asked Questions

Click here to add yourself to our mailing list and be the first to know about new RFAs.

ACCELERATION INITIATIVE - COMPLETED PROJECTS

You Can Help End Childhood Cancer

Pin It on Pinterest